GO:0006517 protein deglycosylation: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0006517 (protein deglycosylation) is the biological process that removes sugar residues from glycosylated proteins, reversing glycosylation and regulating protein fate.
• Enzymatic deglycosylation is widely used as a research tool to improve protein crystallization and to probe structure-function relationships of glycoproteins.
• NGLY1 is a central cytosolic peptide:N-glycanase that removes N-glycans from misfolded glycoproteins and is linked to a rare congenital disorder of deglycosylation.
• Deglycosylation of viral proteins such as NS1 modulates virion assembly and infectivity in orthoflaviviruses.
• Immobilized PNGase F on magnetic nanoparticles enables native-condition protein deglycosylation, expanding biotechnological applications.
• Defects in deglycosylation pathways are associated with human disease, including NGLY1 deficiency and altered glycoprotein function in cancer and infection.
Description
Protein deglycosylation (GO:0006517) is the biological process that removes sugar residues from glycosylated proteins. This process is essential for protein quality control, as it allows cells to clear misfolded glycoproteins and recycle glycans. Beyond its cellular roles, deglycosylation is a fundamental tool in biochemistry and structural biology, enabling researchers to study protein structure and function without the confounding effects of heterogeneous glycan chains. The importance of protein deglycosylation extends to virology, where the removal of N-linked glycans from viral proteins such as NS1 affects virion assembly and infectivity. In this article, we explore the definition, mechanism, key genes, and research methods associated with GO:0006517, providing a comprehensive resource for researchers studying glycoprotein biology.
protein deglycosylation At A Glance
| GO ID | GO:0006517 |
|---|---|
| GO term | protein deglycosylation |
| Ontology | biological_process |
| Synonym | glycoprotein deglycosylation |
| Major function | Removal of sugar residues from glycosylated proteins |
| Related enzymes | NGLY1, PNGase F, endoglycosidases |
| Subcellular location | Cytosol, endoplasmic reticulum, extracellular |
| Disease relevance | NGLY1 deficiency, viral infection, cancer |
What Is GO:0006517?
According to the Gene Ontology, protein deglycosylation (GO:0006517) is defined as the removal of sugar residues from a glycosylated protein. This process can occur enzymatically, often through the action of glycosidases such as peptide:N-glycanase (NGLY1) or endoglycosidases, and is critical for maintaining protein homeostasis and regulating protein function.
Why Is protein deglycosylation Important in Cell Biology?
Protein deglycosylation is crucial for protein quality control, as it enables the removal of misfolded glycoproteins from the endoplasmic reticulum and their subsequent degradation. This process also regulates the function of numerous glycoproteins, including viral proteins that require specific glycosylation states for assembly and infectivity. In biotechnology, enzymatic deglycosylation is indispensable for structural studies, as it reduces glycan heterogeneity that can hinder crystallization. Furthermore, defects in deglycosylation pathways are linked to human diseases such as NGLY1 deficiency, underscoring its biomedical significance.
• Enables protein quality control by removing N-glycans from misfolded glycoproteins for degradation.
• Regulates viral protein function, as deglycosylation of NS1 affects virion assembly in orthoflaviviruses.
• Facilitates structural biology by reducing glycan heterogeneity for crystallization.
• Plays a role in immune recognition and clearance of glycoproteins.
• Is essential for normal development, as NGLY1 mutations cause a severe congenital disorder.
• Provides a tool for biotechnological applications, such as immobilized PNGase F for native deglycosylation.
• Impacts cancer biology through altered glycosylation and deglycosylation of tumor-associated proteins.
• Contributes to host-pathogen interactions by modifying viral glycoproteins.
What Happens During protein deglycosylation?
Recognition of Glycosylated Proteins
In simple terms: The cell identifies proteins that have sugar chains attached to them.
The first step in protein deglycosylation involves the recognition of glycosylated proteins by specific enzymes. For N-linked glycans, the cytosolic peptide:N-glycanase NGLY1 recognizes misfolded glycoproteins that have been retrotranslocated from the endoplasmic reticulum. This recognition is often mediated by lectin-like domains that bind to the glycan moiety, ensuring that only properly glycosylated substrates are targeted.
Enzymatic Cleavage of Sugar Residues
In simple terms: Enzymes cut the sugar chains off the protein.
Once recognized, glycosidases catalyze the hydrolysis of the glycosidic bond between the sugar residue and the protein or between sugar residues. NGLY1 cleaves the entire N-glycan from asparagine residues, releasing free oligosaccharides. Other enzymes, such as endoglycosidases, can cleave within the glycan chain, leaving a single N-acetylglucosamine residue attached. The choice of enzyme determines the extent of deglycosylation and the resulting protein product.
Release of Free Glycans and Protein Processing
In simple terms: The removed sugars are released, and the protein is further processed or degraded.
After cleavage, the free glycans are released and can be further degraded or recycled. The deglycosylated protein may then undergo quality control steps, such as ubiquitination and proteasomal degradation if it is misfolded. Alternatively, the protein may be redirected to its functional location if it is properly folded. This step is critical for maintaining cellular homeostasis and preventing the accumulation of damaged glycoproteins.
Regulation of Deglycosylation in Disease
In simple terms: When deglycosylation goes wrong, it can lead to disease.
Dysregulation of protein deglycosylation is associated with various diseases. Mutations in NGLY1 cause a rare congenital disorder characterized by developmental delay, seizures, and liver dysfunction. In viral infections, deglycosylation of viral proteins such as NS1 can affect virion assembly and infectivity. Additionally, altered deglycosylation of host proteins has been implicated in cancer progression and immune evasion.
Key Genes Involved in GO:0006517 protein deglycosylation
The following genes and proteins are key players in protein deglycosylation, as supported by published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| NGLY1 | Cytosolic peptide:N-glycanase that removes N-glycans from misfolded glycoproteins | Mutations cause NGLY1 deficiency; model for congenital disorders of deglycosylation |
| PNGase F | Bacterial enzyme that cleaves N-linked glycans from asparagine residues | Widely used in biotechnology for deglycosylation under native conditions |
| ENGase | Endo-beta-N-acetylglucosaminidase that cleaves within the N-glycan core | Involved in glycan processing and quality control |
| NS1 | Non-structural protein of orthoflaviviruses; N-linked glycosylation modulates virion assembly | Target for studying viral deglycosylation and infectivity |
| Band 3 | Anion transport protein of erythrocyte membrane; deglycosylation affects structure and transport | Model for studying deglycosylation effects on membrane proteins |
| Tamm-Horsfall protein | Glycoprotein involved in urinary tract defense; deglycosylation alters immunoreactivity | Used to study desialylation and deglycosylation effects on immune recognition |
| Dengue NS1 | Glycoprotein essential for dengue virus replication; deglycosylation affects virus viability | Model for dengue virus pathogenesis and vaccine development |
| O-Glycanases | Enzymes that remove O-linked glycans | Important for characterizing O-glycoproteins and their functions |
| Glycosyltransferases | Enzymes that add sugars to proteins; counterbalance deglycosylation | Studied in context of glycosylation homeostasis |
| Lectin chaperones | Recognize glycans and facilitate deglycosylation | Involved in ER-associated degradation |
| Ubiquitin ligases | Tag deglycosylated proteins for degradation | Link deglycosylation to proteasomal degradation |
| Proteasome subunits | Degrade deglycosylated proteins | Downstream effectors of deglycosylation pathway |
| Viral glycoproteins | Require glycosylation for function; deglycosylation modulates infectivity | Targets for antiviral research |
| Host glycoproteins | Subject to deglycosylation in infection and cancer | Biomarkers and therapeutic targets |
| PNGase A | Plant enzyme with similar activity to PNGase F | Alternative tool for deglycosylation |
| Endo H | Endoglycosidase that cleaves high-mannose N-glycans | Used in glycoprotein analysis |
How Is protein deglycosylation Regulated?
Protein deglycosylation is regulated at multiple levels. The expression and activity of NGLY1 are controlled by cellular stress pathways, including the unfolded protein response, which upregulates deglycosylation machinery to cope with misfolded protein accumulation. Additionally, the subcellular localization of deglycosylation enzymes is tightly regulated; NGLY1 is primarily cytosolic, where it encounters retrotranslocated glycoproteins. Post-translational modifications, such as phosphorylation, may also modulate enzyme activity, although specific mechanisms remain to be fully elucidated.
protein deglycosylation and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| NGLY1 | NGLY1 deficiency (congenital disorder of deglycosylation) | Knockout mouse, patient-derived iPSCs, C. elegans |
| NS1 | Orthoflavivirus infection (e.g., dengue, Zika) | Viral mutants with deglycosylation sites removed, cell culture |
| Band 3 | Eryrocyte membrane transport defects | In vitro deglycosylation assays, erythrocyte membranes |
| Tamm-Horsfall protein | Urinary tract infections and kidney stones | Deglycosylation studies in urine samples |
| O-Glycans | Cancer and immune disorders | O-glycanase treatment, mass spectrometry |
NGLY1 Deficiency: A Congenital Disorder of Deglycosylation
Mutations in NGLY1 cause a rare autosomal recessive disorder characterized by developmental delay, seizures, movement disorders, and liver dysfunction. This condition highlights the critical role of protein deglycosylation in human health. Studies in model organisms such as Caenorhabditis elegans have provided insights into the molecular mechanisms underlying NGLY1 deficiency and potential therapeutic approaches.
Viral Infections: Deglycosylation of Viral Proteins
Many viruses rely on glycosylation of their envelope proteins for proper folding, assembly, and immune evasion. Deglycosylation of viral proteins such as NS1 in orthoflaviviruses can impair virion assembly and reduce infectivity. In dengue virus, deglycosylation of NS1 affects viral replication and pathogenesis, making it a potential target for antiviral strategies.
Cancer: Altered Glycosylation and Deglycosylation
Cancer cells often exhibit aberrant glycosylation patterns, and deglycosylation of tumor-associated proteins can influence cell signaling, immune recognition, and metastasis. Understanding how deglycosylation contributes to cancer biology may reveal new therapeutic targets and biomarkers.
From protein deglycosylation-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does NGLY1 knockout affect glycoprotein degradation? | NGLY1 knockout cell lines (e.g., HEK293, HeLa) |
| How does deglycosylation of NS1 affect viral assembly? | Point mutations at N-glycosylation sites in NS1, viral infection assays |
| Can deglycosylation be used to improve protein crystallization? | Recombinant glycosidase treatment, X-ray crystallography |
| What is the role of O-glycosylation in cancer? | O-glycanase overexpression or knockout in cancer cell lines |
| How does deglycosylation affect Band 3 transport function? | In vitro deglycosylation of Band 3, transport assays |
| Can immobilized PNGase F be used for native deglycosylation? | Magnetic nanoparticle-immobilized PNGase F, mass spectrometry |
How to Study the protein deglycosylation Process
| Method | What It Measures | Typical Application |
|---|---|---|
| PNGase F treatment | Removal of N-linked glycans | Protein deglycosylation for SDS-PAGE or mass spectrometry |
| Endo H treatment | Cleavage of high-mannose N-glycans | Analysis of glycoprotein processing |
| O-glycanase treatment | Removal of O-linked glycans | Characterization of O-glycoproteins |
| Mass spectrometry | Glycan composition and structure | Glycomics and deglycosylation analysis |
| Crystallography | Three-dimensional protein structure | Structural studies of deglycosylated proteins |
| Transport assays | Protein function (e.g., anion transport) | Functional analysis of deglycosylated Band 3 |
| Viral infectivity assays | Viral replication and assembly | Studying deglycosylation effects on viruses |
| Immunoreactivity assays | Antibody binding to deglycosylated proteins | Assessing immune recognition after deglycosylation |
Enzymatic Deglycosylation Assays
Enzymatic deglycosylation is commonly performed using glycosidases such as PNGase F, Endo H, or O-glycanase. These enzymes cleave specific glycan linkages and can be used under native or denaturing conditions. Immobilized enzymes on magnetic nanoparticles allow for efficient deglycosylation and easy removal, making them suitable for biotechnological applications.
Mass Spectrometry for Glycan Analysis
Mass spectrometry is a powerful method for characterizing glycans released by deglycosylation. It can identify the composition and structure of N- and O-linked glycans, providing insights into glycosylation patterns and enzyme specificity. This approach is essential for studying the effects of deglycosylation on protein function.
Structural Biology: Crystallization after Deglycosylation
Deglycosylation is often a prerequisite for protein crystallization, as heterogeneous glycans can impede crystal formation. Recombinant glycosidases are used to remove glycans, and the deglycosylated protein is then subjected to crystallization trials. This method has been successfully applied to many glycoproteins, revealing their three-dimensional structures.
Functional Assays for Deglycosylated Proteins
After deglycosylation, proteins can be tested for functional changes using biochemical assays. For example, deglycosylation of Band 3 affects its anion transport properties, which can be measured in erythrocyte membranes. Similarly, deglycosylation of viral proteins can be assessed for effects on infectivity and assembly.
How CRISPR Can Be Used to Study GO:0006517 protein deglycosylation
Knockout
CRISPR knockout of deglycosylation genes such as NGLY1 allows researchers to study the consequences of loss of function. NGLY1 knockout cell lines exhibit accumulation of misfolded glycoproteins and impaired ER-associated degradation, providing insights into NGLY1 deficiency. These models are valuable for testing therapeutic strategies and understanding disease mechanisms.
Point Mutation
Point mutations can be introduced into glycosylation sites of target proteins to prevent glycan attachment, mimicking deglycosylation. For example, mutating the N-glycosylation sites of NS1 in orthoflaviviruses abolishes glycosylation and affects virion assembly. Such models help dissect the role of specific glycans in protein function.
Knock-in
Knock-in of tagged or mutant versions of deglycosylation enzymes enables real-time tracking and functional studies. For instance, knocking in a fluorescently tagged NGLY1 allows visualization of its subcellular localization and dynamics. This approach is useful for understanding how deglycosylation enzymes are regulated in living cells.
Overexpression
Overexpression of deglycosylation enzymes such as PNGase F or NGLY1 can enhance deglycosylation capacity, leading to reduced glycan levels on target proteins. This is useful for producing deglycosylated proteins for structural studies or for investigating the effects of excessive deglycosylation on cellular processes.
How EDITGENE Supports protein deglycosylation Research
Researchers studying protein deglycosylation-related genes often need to determine whether a candidate gene is causally involved in the process or is merely correlated with it. EDITGENE provides a comprehensive suite of CRISPR services to enable precise genetic manipulation and functional interrogation of deglycosylation pathways.
Contact EDITGENE today to design your custom CRISPR model for protein deglycosylation research.
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| OGA Knockout HEK293 Cell Line | EDJ-KQ2049 | Human | 10724 | Details Get a Quote |
| AGA Knockout HEK293 Cell Line | EDJ-KQ3361 | Human | 175 | Details Get a Quote |
| OGA Knockout A-549 Cell Line | EDJ-KQ22103 | Human | 10724 | Details Get a Quote |
| OGA Knockout HCT 116 Cell Line | EDJ-KQ22104 | Human | 10724 | Details Get a Quote |
| OGA Knockout HeLa Cell Line | EDJ-KQ22105 | Human | 10724 | Details Get a Quote |
| AGA Knockout A-549 Cell Line | EDJ-KQ25025 | Human | 175 | Details Get a Quote |
| AGA Knockout HCT 116 Cell Line | EDJ-KQ25026 | Human | 175 | Details Get a Quote |
| AGA Knockout HeLa Cell Line | EDJ-KQ25027 | Human | 175 | Details Get a Quote |
Displaying Records 1 To 8 Of 8 Records
Frequently Asked Questions About protein deglycosylation
What is protein deglycosylation?
Protein deglycosylation is the biological process of removing sugar residues from glycosylated proteins, as defined by GO:0006517.
What genes are involved in protein deglycosylation?
Key genes include NGLY1, which encodes a peptide:N-glycanase, and other glycosidases such as ENGase and PNGase F.
What is the role of NGLY1 in deglycosylation?
NGLY1 is a cytosolic enzyme that removes N-linked glycans from misfolded glycoproteins, facilitating their degradation.
How is protein deglycosylation studied?
Common methods include enzymatic treatment with glycosidases, mass spectrometry, and structural biology techniques such as crystallography.
What diseases are associated with defective deglycosylation?
NGLY1 deficiency is a congenital disorder caused by mutations in NGLY1, leading to developmental delay and other symptoms.
Can deglycosylation affect viral infectivity?
Yes, deglycosylation of viral proteins such as NS1 in orthoflaviviruses can impair virion assembly and reduce infectivity.
What is the difference between N-glycosylation and O-glycosylation?
N-glycosylation attaches sugars to asparagine residues, while O-glycosylation attaches sugars to serine or threonine residues; both can be removed by specific enzymes.
Why is deglycosylation important for protein crystallization?
Removing heterogeneous glycans reduces structural heterogeneity, improving the chances of obtaining well-diffracting crystals.
What are the tools for enzymatic deglycosylation?
PNGase F, Endo H, and O-glycanase are commonly used; immobilized versions on magnetic nanoparticles allow native-condition deglycosylation.
How does CRISPR help study protein deglycosylation?
CRISPR can create knockout, point mutation, and knock-in models to dissect the function of deglycosylation genes and their roles in disease.
Conclusion
Protein deglycosylation (GO:0006517) is a fundamental biological process with wide-ranging implications for protein quality control, viral infection, and human disease. Understanding its mechanisms and regulation is essential for developing therapeutic strategies for conditions such as NGLY1 deficiency and viral infections. Advances in CRISPR technology and biochemical tools continue to drive research in this field, offering new opportunities to manipulate and study deglycosylation pathways.
References
- 1. Lehrbach NJ. 2022. NGLY1: insights from Caenorhabditis elegans.. J Biochem 171(2):145-152 PMID: 34697631
- 2. Bidondo L et al.. 2022. Immobilized peptide-N-glycosidase F onto magnetic nanoparticles: A biotechnological tool for protein deglycosylation under native conditions.. Biotechnol Appl Biochem 69(1):209-220 PMID: 33438294
- 3. Grueninger-Leitch F et al.. 1996. Deglycosylation of proteins for crystallization using recombinant fusion protein glycosidases.. Protein Sci 5(12):2617-22 PMID: 8976570
- 4. Casey JR et al.. 1992. Enzymatic deglycosylation of human Band 3, the anion transport protein of the erythrocyte membrane. Effect on protein structure and transport properties.. J Biol Chem 267(17):11940-8 PMID: 1601863
- 5. Zhang S et al.. 2026. N-linked glycosylation of NS1 protein modulates progeny virion assembly in orthoflaviviruses.. PLoS Pathog 22(7):e1014408 PMID: 42424390
- 6. Grabska T et al.. 1996. Alterations of Tamm-Horsfall protein immunoreactivity after partial desialylation and deglycosylation.. Arch Immunol Ther Exp (Warsz) 44(4):241-8 PMID: 9017164
- 7. Crabtree MB et al.. 2005. Deglycosylation of the NS1 protein of dengue 2 virus, strain 16681: construction and characterization of mutant viruses.. Arch Virol 150(4):771-86 PMID: 15592895
- 8. Wilkinson H et al.. 2020. Current Methods for the Characterization of O-Glycans.. J Proteome Res 19(10):3890-3905 PMID: 32893643
